Venus Remedies Limited has received approval from the Government of India under PLI 2.0 of the Production Linked Incentive Scheme (PLI) for manufacturers of pharmaceutical goods registered in India.
Venus is one of the 10 non-MSME pharmaceutical companies under category-C which have been granted approval under the PLI Scheme. As per the scheme, the Company will be eligible for incentive for the financial years 2022-23 to 2027-28, subject to fulfilment of minimum investment criteria and based on incremental sales of eligible products as per the scheme guidelines.
Shares of Venus Remedies Limited was last trading in BSE at Rs. 470.05 as compared to the previous close of Rs. 451.20. The total number of shares traded during the day was 15185 in over 1711 trades.
The stock hit an intraday high of Rs. 474.80 and intraday low of 451.20. The net turnover during the day was Rs. 7062675.00.